Carmen Gherasim

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2”.

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

Nature(2022)10.1038/s41586-022-04856-1

N/A

10.7DataRank · unranked

293 citations

Maki Kiso, Shun Iida, Masaki Imai, Emi Takashita, Makoto Kuroda +64 more

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1

Cell Host & Microbe(2024)10.1016/j.chom.2024.01.014

N/A

7.6DataRank · unranked

179 citations

Yicheng Guo, Anthony Bowen, Ian A. Mellis, Riccardo Valdez, Carmen Gherasim +4 more

The human B12 trafficking protein CblC processes nitrocobalamin

Journal of Biological Chemistry(2020)10.1074/jbc.ra120.014094

N/A

0.800DataRank · unranked

27 citations

Zhu Li, Carmen Gherasim, Markus Ruetz, Ruma Banerjee, Romila Mascarenhas

Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants

Cell Reports(2025)10.1016/j.celrep.2025.116440

N/A

0.510DataRank · unranked

29 citations

Madeline Wu, Hsiang Hong, Chih-Chen Tzang, Anthony Bowen, Qian Wang +9 more

Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing

Frontiers in Immunology(2023)10.3389/fimmu.2023.1055429

N/A

0.345DataRank · unranked

9 citations

Charles F. Schuler, Jesse Chen, Jonathan P. Troost, Pamela T. Wong, Kelsea Chen +8 more

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.26.568730

N/A

0DataRank · unranked

43 citations

Yicheng Guo, Anthony Bowen, Ian A. Mellis, Riccardo Valdez, Carmen Gherasim +4 more

Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101701

N/A

0DataRank · unranked

11 citations

Ian A. Mellis, Yicheng Guo, Carmen Gherasim, Riccardo Valdez, Aubree Gordon +3 more

Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC

Cell Reports(2025)10.1016/j.celrep.2025.115543

N/A

0DataRank · unranked

41 citations

Yicheng Guo, Ian A. Mellis, Madeline Wu, Hiroshi Mohri, Carmen Gherasim +6 more

KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00058-1

N/A

0DataRank · unranked

21 citations

Ian A. Mellis, Madeline Wu, Anthony Bowen, Carmen Gherasim, Riccardo Valdez +7 more

Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.18.662329

N/A

0DataRank · unranked

8 citations

Madeline Wu, Hsiang Hong, Chih-Chen Tzang, Anthony Bowen, Qian Wang +9 more

Do Existing COVID-19 Vaccines Need to Be Updated in 2025?

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.02.651777

N/A

0DataRank · unranked

5 citations

Madeline Wu, Qian Wang, Anthony Bowen, Carmen Gherasim, Riccardo Valdez +7 more

Characterization of a new SARS-CoV-2 variant that emerged in Brazil

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2106535118

N/A

0DataRank · unranked

87 citations

Peter Halfmann, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, S. Chiba, Tokiko Watanabe +54 more

Accurate point-of-care serology tests for COVID-19

PLoS ONE(2021)10.1371/journal.pone.0248729

N/A

0DataRank · unranked

21 citations

Carmen Gherasim, Kelly O’Shea, David M. Manthei, Jesse Chen, Don Giacherio +4 more

Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies

Microbiology Spectrum(2021)10.1128/spectrum.00087-21

N/A

0DataRank · unranked

21 citations

Carmen Gherasim, Kelly J. O’Shea, David M. Manthei, Jesse Chen, Cristyn Zettel +8 more

Antibody Response to Omicron BA.4–BA.5 Bivalent Booster

New England Journal of Medicine(2023)10.1056/nejmc2213907

N/A

0DataRank · unranked

212 citations

Anthony Bowen, Riccardo Valdez, Carmen Gherasim, Aubree Gordon, Lihong Liu +2 more